Literature DB >> 10213466

Increased release of transforming growth factor (TGF)-beta1, TGF-beta2, and chemoattractant mediators in pneumonia.

F Bühling1, G Thölert, D Kaiser, B Hoffmann, D Reinhold, S Ansorge, T Welte.   

Abstract

Transforming growth factor-beta (TGF-beta), interleukin-8 (IL-8), and leukotrienes are potent neutrophil chemoattractants that are released in several lung diseases. There is limited information about the release of TGF-beta in bronchoalveolar lavage fluid (BALF) of patients with pneumonia. Furthermore, it is not clear if TGF-beta is differentially expressed in different lung diseases. The aim of our study was to compare the concentrations of TGF-beta1 and TGF-beta2 in the BALF of patients with pneumonia and other lung diseases. Furthermore, correlation of the TGF-beta levels with the concentration of chemoattractant mediators as well as with indicators of macrophage and granulocyte activation should be investigated. Patients with pneumonia, interstitial lung disease (ILD), or chronic obstructive pulmonary diseases (COPD) were included. Patients with ischemic heart disease without pulmonary involvement served as controls. The concentrations of TGF-beta1 and TGF-beta2, of the chemoattractant cytokine IL-8, of leukotriene B4, and of the leukotrienes C4, D4, and E4 were measured. Neutrophil elastase and granulocyte content (PMN) were used as markers for granulocyte activation, and neopterin was used as a marker for the activation of macrophages. Significantly elevated levels of TGF-beta1 (mean = 0.216 ng/ml, p < 0.01) were found in patients with microbiologically positive pneumonia but not in patients with ILD or COPD. A significant (p < 0.001) correlation was found between the TGF-beta1 concentrations and the IL-8 levels and the percentage of granulocytes (r = 0.76, and r = 0.44, respectively). Elevated TGF-beta2 concentrations were measured in the BALF of patients with pneumonia (mean = 1.4 ng/ml, p < 0.01) and with ILD. Pneumonia was also associated with increased concentrations of leukotrienes C4, D4, and E4 (mean = 91.61 pg/ml, p < 0.05) and leukotriene B4 (mean = 203.9 pg/ml, p < 0.01), significantly elevated levels of PMN elastase (mean = 2958.26 ng/ml, p < 0.01), and neopterin (mean = 0.42 nmol/L). Our results strongly suggest that different lung diseases do differ with regard to the released cytokines. TGF-beta1 probably plays a key role in regulation of pulmonary inflammation, particularly in pneumonia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10213466     DOI: 10.1089/107999099314207

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  7 in total

1.  Poly-ADP-ribose polymerase inhibition provides protection against lung injury in a rat paraquat toxicity model.

Authors:  Salim Kemal Tuncer; Seher Altinel; Mehmet Toygar; Hakan Istanbulluoglu; Kahraman Ates; Recai Ogur; Ozcan Altinel; Yildirim Karslioglu; Turgut Topal; Ahmet Korkmaz; Bulent Uysal
Journal:  Inflammopharmacology       Date:  2016-06-07       Impact factor: 4.473

2.  The significance of interleukin 8 in urine.

Authors:  W H Rao; G S Evans; A Finn
Journal:  Arch Dis Child       Date:  2001-09       Impact factor: 3.791

3.  Pirfenidone modulates airway responsiveness, inflammation, and remodeling after repeated challenge.

Authors:  Atsushi Hirano; Arihiko Kanehiro; Katsuichiro Ono; Wataru Ito; Akio Yoshida; Chiharu Okada; Hiromi Nakashima; Yasushi Tanimoto; Mikio Kataoka; Erwin W Gelfand; Mitsune Tanimoto
Journal:  Am J Respir Cell Mol Biol       Date:  2006-05-04       Impact factor: 6.914

4.  Cigarette smoke extract induces a phenotypic shift in epithelial cells; involvement of HIF1α in mesenchymal transition.

Authors:  Irene M J Eurlings; Niki L Reynaert; Twan van den Beucken; Harry R Gosker; C C de Theije; Fien M Verhamme; Ken R Bracke; Emiel F M Wouters; Mieke A Dentener
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

5.  Transforming Growth Factor-β1 in predicting early lung fibroproliferation in patients with acute respiratory distress syndrome.

Authors:  Jean-Marie Forel; Christophe Guervilly; Catherine Farnarier; Stéphane-Yannis Donati; Sami Hraiech; Nicolas Persico; Jérôme Allardet-Servent; Benjamin Coiffard; Marc Gainnier; Anderson Loundou; Aude Sylvestre; Antoine Roch; Jeremy Bourenne; Laurent Papazian
Journal:  PLoS One       Date:  2018-11-05       Impact factor: 3.240

6.  Eosinophilic Pneumonia Putatively Induced by Vancomycin: A Case Report.

Authors:  Tomomi Isono; Hirochiyo Sawaguchi; Hidenori Kusumoto; Hiroyuki Shiono
Journal:  Am J Case Rep       Date:  2019-09-30

7.  Similar matrix alterations in alveolar and small airway walls of COPD patients.

Authors:  Irene M J Eurlings; Mieke A Dentener; Jack P M Cleutjens; Carine J Peutz; Gernot G U Rohde; Emiel F M Wouters; Niki L Reynaert
Journal:  BMC Pulm Med       Date:  2014-05-26       Impact factor: 3.317

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.